Mr. Alan Simpson reports

PHARMACORP ANNOUNCES CFO TRANSITION AND APPOINTMENT OF ANDREW HODSON AS CHIEF FINANCIAL OFFICER

Andrew Hodson will join Pharmacorp Rx Inc. effective Oct. 27, 2026, as its chief financial officer.

Mr. Hodson will succeed current CFO Terri Tatchell, who will retire from the role on the same date. Mrs. Tatchell will remain with the corporation for three months as a consultant to assist with the transition of CFO responsibilities.

The appointment comes as Pharmacorp continues to execute its strategy of buying, integrating and operating high-quality pharmacies across Canada.

"Terri has contributed significantly to Pharmacorp throughout her tenure and we are grateful for her service and dedication," said Alan Simpson, executive chair of Pharmacorp. "On behalf of the board and the entire team, we thank her for her contributions and continued support through this handover."

Mr. Simpson continued: "We are excited to add Andrew to the team as we focus on accelerating the growth of our business. Andrew's experience building and leading finance teams and supporting acquisitions aligns directly with our strategy as we expand Pharmacorp's pharmacy network. We believe Pharmacorp's unique access to a pipeline of strong Canadian pharmacies, coupled with our disciplined M&A processes, positions the corporation to achieve significant growth going forward."

Mr. Hodson's background

Mr. Hodson brings to Pharmacorp more than 11 years of progressive financial leadership experience consisting of financial strategy development and implementation, transaction support, and includes over six years leading global finance organizations in high-growth and acquisition-driven businesses.

Before joining Pharmacorp, he was head of finance for Marshall Land Systems Ltd., where he led financial reporting across its Canadian and United Kingdom entities.

He was previously vice-president of finance for Vendasta Technologies Inc., a Saskatoon-based software company specializing in digital business solutions provided through channel partners to their small and medium-sized business clients.

At Vendasta, Mr. Hodson led finance work streams for strategic acquisitions, including financial due diligence, valuation, transaction support, integration planning and postacquisition financial integration. He also supported capital markets initiatives, including the development of prospectus materials, preparation for a capital raise and shareholder communications.

Before Vendasta, Mr. Hodson was at Deloitte Canada for six years, where he led audit engagements for private and public companies across the technology and software-as-a-service (SaaS) sectors.

At Deloitte, he also advised client executive teams on financial reporting, internal controls, accounting standards and regulatory compliance.

Mr. Hodson is a chartered professional accountant with a master of professional accounting degree from the University of Saskatchewan.

About Pharmacorp Rx Inc.

Pharmacorp is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. Through a combination of capital, strategic support and operational expertise, Pharmacorp is building a national network of community pharmacies under the PharmaChoice Canada banner.

Pharmacorp operates 17 PharmaChoice Canada-bannered pharmacies and intends to continue acquiring both PharmaChoice Canada-bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform in accordance with its partnership with PharmaChoice Canada, where applicable. Pharmacorp shares trade on the TSX Venture Exchange under the symbol PCRX.

Pharmacorp welcomes discussions with pharmacy owners considering succession or sale.

We seek Safe Harbor.